BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 15472409)

  • 21. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.
    Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H
    Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of association between the glutathione-s-transferase genes (GSTT1 and GSTM1) and nasal polyposis.
    Arbag H; Cora T; Acar H; Ozturk K; Sari F; Ulusoy B
    Rhinology; 2006 Mar; 44(1):14-8. PubMed ID: 16550944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.
    Mo Z; Gao Y; Cao Y; Gao F; Jian L
    Prostate; 2009 May; 69(6):662-88. PubMed ID: 19143011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer.
    Srivastava DS; Mishra DK; Mandhani A; Mittal B; Kumar A; Mittal RD
    Eur Urol; 2005 Aug; 48(2):339-44. PubMed ID: 16005379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
    Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
    Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].
    Guan TY; Li M; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
    Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk.
    Jourenkova-Mironova N; Voho A; Bouchardy C; Wikman H; Dayer P; Benhamou S; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):185-8. PubMed ID: 10067818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk.
    Tamer L; Ateş NA; Ateş C; Ercan B; Elipek T; Yildirim H; Camdeviren H; Atik U; Aydin S
    Cell Biochem Funct; 2005; 23(4):267-72. PubMed ID: 15473001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD).
    Faramawy MM; Mohammed TO; Hossaini AM; Kashem RA; Abu Rahma RM
    J Crit Care; 2009 Sep; 24(3):e7-10. PubMed ID: 19664521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population.
    Sharma A; Sharma JK; Murthy NS; Mitra AB
    Neoplasma; 2004; 51(1):12-6. PubMed ID: 15004652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
    Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
    Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of passive smoking with GST (GSTM1, GSTT1, and GSTP1) genotypes in the risk of cervical cancer in India.
    Sobti RC; Kaur S; Kaur P; Singh J; Gupta I; Jain V; Nakahara A
    Cancer Genet Cytogenet; 2006 Apr; 166(2):117-23. PubMed ID: 16631467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) polymorphisms in a sample of the population in Northern Italy.
    Bigatti MP; Santovito A
    Genetika; 2007 Jun; 43(6):827-30. PubMed ID: 17853809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer.
    Oude Ophuis MB; Manni JJ; Peters WH
    Acta Otolaryngol; 2006 Mar; 126(3):311-7. PubMed ID: 16618661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.